Mercy Health Services Center Selects Bernoulli for Medical Device Integration into Epic

Bernoulli will be part of perioperative EHR go-live in 2018

Milford, CT—August 1, 2017.

Mercy Health Services in Baltimore chose Bernoulli, the leader in real-time patient safety, to deliver medical device integration / connectivity to the health system’s perioperative suite.

The company will implement its Bernoulli One architecture in anesthesia devices during the health system’s transition to Epic.

“Bernoulli has a great deal of experience working with Epic,” said John Goldbeck, Senior Programmer Analyst for Mercy Health Services. “They possess the capabilities to deliver a fully integrated, system-wide platform with comprehensive device connectivity.”

Bernoulli will implement its proven Bernoulli One architecture to bring medical device connectivity to anesthesia devices in Mercy’s perioperative suite at Mercy.

Bernoulli One offers detailed data schemes, functional assessment and clinical support for myriad medical devices. It uses a standard HL7 interface and existing network infrastructure to automatically capture and distribute data into interfaces and EHR systems.

In addition, Bernoulli One offers the lowest overall cost of ownership and highest level of patient data security and privacy. It also features plug-and-play connectivity and integrated clinical mobility.

“Installing a new EHR requires a collaborative relationship between solutions providers and multiple stakeholders,” said Bernoulli CEO Janet Dillione. “We are excited to play a critical role in Mercy’s journey toward improved clinical workflows and patient safety.”

Founded in 1874, Mercy Medical Center is a university-affiliated medical facility with a national reputation for women’s health. Mercy is home to the nationally acclaimed Weinberg Center for Women’s Health and Medicine as well as the $400+ million, 20-story Mary Catherine Bunting Center. For more information visit  Mercy online and MDMercyMedia on Facebook and Twitter.

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One, the only real-time, connected healthcare platform. It combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities.  We offer the ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow.   For more information about Bernoulli, visit www.bernoullihealth.com. Follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.

Study: Real-Time Analytics, Continuous Monitoring Mitigates Threat of Respiratory Depression

Peer-reviewed results of patented surveillance application reveals promise of real-time patient safety initiatives in hospitals and health systems

Milford, CT—May 24, 2017—Bernoulli, the leader in real-time solutions for patient safety, announced the publication of a peer-reviewed study demonstrating the use of patented real-time analytics, medical device connectivity and combinatorial alarms to provide remote centralized continuous monitoring of post-surgical patients at risk for opioid-induced respiratory depression (OIRD).

Continuous Surveillance of Sleep Apnea Patients in a Medical-Surgical Unit1 in the May/June 2017 issue of the Journal of Biomedical Instrumentation & Technology consists of two separate studies on the use of continuous capnography monitoring at a medical-surgical unit at Virtua Health System in New Jersey.

The study’s results suggest that combinatorial alarm signals based on multi-parameter assessment reduced overall load better than individual-parameter sustained alarm signals and appeared to be more effective at identifying at-risk patients.

Using only sustained alarms as the filter for notifications reduced alerts from 22,812 to 13,000. However, passing multiple series of data through a multi-variable rules engine that monitored the values of pulse (HR), oxygen saturation (SpO2), respiratory rate (RR), and end-tidal carbon dioxide (ETCO2) in order to determine which alarms to send to the nurse-call phone system further reduced alerts to just 209—a 99% reduction.

“More importantly, clinical staff was alerted for every patient that experienced an actual respiratory depression episode,” said the study’s co-author, John Zaleski, PhD, CAP, CPHIMS, Chief Analytics Officer of Bernoulli. “The successful implementation of real-time patient safety initiatives have long been a goal of health system CIOs, but recognizing and responding to signs of patient deterioration requires medical devices connectivity as well as clinician’s access to real-time data.”

A Growing Patient Safety Threat
The use of opioids, such as hydromorphone and morphine sulfate, are known to increase risk of respiratory depression in patients who have been diagnosed with or are at risk for obstructive sleep apnea (OSA).

More than half of medication-related deaths and 20,000 incidences of respiratory depression-related interventions annually are attributed to the delivery of opioids in a care setting, at a cost of approximately $2 billion per year to the U.S. healthcare system.

“Data from multiple sources may be required to achieve improvements in patient safety, including the EHR and real-time data from medical devices,” said Zaleski. “Moment-to-moment changes in patient vitals are not usually available in the long-term clinical record, so a hybrid approach involving both real-time and aperiodic and discrete data is required to improve the overall surveillance of these patients.”

Respiratory Depression Safety Surveillance
The solution leveraged in the study, Bernoulli’s Respiratory Depression Safety Surveillance (RDSS), includes patented analytics with multi-variable thresholds—adjustable by the care facility—to identify clinically actionable events while significantly reducing the overall number of alarms communicated to remote and mobile clinicians, mitigating the risk of alarm fatigue.

RDSS is flexible, adaptable and scalable from individual departments to enterprise-wide deployments. Its vendor-neutral architecture leverages the hospital’s existing investments in IT, network, wireless and mobile infrastructure, while its FDA class II clearance includes indications for use to provide remote monitoring and alarm surveillance.

Implications for Real-Time Healthcare
“Combining analysis with real-time data at the point of collection creates a powerful tool for prediction and clinical decision support,” said Zaleski. “The ability to track patients throughout the hospital, continuously add new devices, and distribute real-time patient monitoring to centralized dashboards and mobile devices should be a major consideration for CIOs tasked with achieving real-time healthcare capabilities.”

Beyond high-acuity areas, healthcare systems are creating a foundation for other real-time healthcare innovations, including clinical surveillance modules, medical device integration in an EHR and virtual ICUs.

“This study demonstrates the promise of using real-time data for myriad patient safety initiatives,” said Janet Dillione, CEO of Bernoulli. “In addition, Bernoulli’s RDSS solution sets the stage for a wide range of applications, including medical device integration, precision alarm notifications, and clinical surveillance modules in various care settings.”

Reference
1. Supe D, Baron L, Decker T, Parker K, Venella J, Williams S, Beaton K, Zaleski J. A pilot study in middleware-filtered capnography alarms of continuously monitored obstructive sleep apnea patient in a medical-surgical unit. BI&T. May/June 2017.

Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, real-time analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow.

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, real-time analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli One, visit www.bernoullihealth.com. Follow us on LinkedIn and Twitter . Visit our Resource Center to download case studies, white papers and articles.

real time healthcare delivery

Physician Advisors to Consult on Real-Time Healthcare Delivery & Patient Safety Issues

Expertise will Provide Valuable Insights on Supporting Clinical Workflow and Driving Improved Quality of Care

Bernoulli, the leader in real-time solutions for patient safety, announced that two prominent physicians will join the company as consultants to explore issues related to real-time healthcare delivery and increased patient safety.

Neil A Halpern MD & Amar Setty MD

Neil A. Halpern, MD, MCCM, FCCP, FACP, is Director of the Critical Care Center, Chief of the Critical Care Medicine Service and Medical Director of Respiratory Therapy at Memorial Sloan Kettering (MSK) Cancer Center in New York. Dr. Halpern oversees a team of highly experienced doctors, nurse practitioners, physician assistants, respiratory therapists, research and bedside nurses, and critical care programmers who help provide care for patients in MSK’s adult medical-surgical intensive care unit (ICU).

Since 2000, he has co-chaired the hospital’s Clinical Device and Product Evaluation Committee, and since 2014, the Alarm Committee at MSK. Between 2005 and 2007, he chaired the multidisciplinary ICU Design Committee that developed the plan and monitored the construction of MSK’s 20-bed medical-surgical adult ICU, which opened in April 2007.

“There is a clear need in healthcare for greater connectivity, interoperability and comprehensive real-time data to support improved patient safety, enhanced care team collaboration and proactive clinical intervention,” said Dr. Halpern. “I look forward to advising Bernoulli on the applications and services that will have the greatest impact.”

Amar Setty, MD, is the CEO of AnesthesiaStat, a Baltimore-based anesthesia consulting and management company operated by practicing, Board Certified anesthesiologists. In addition to an active private practice, Dr. Setty serves as the immediate-Past President of the Maryland Society of Anesthesiologists, where he continues to be an advocate.

He is working to develop data-centric applications for patient-advocated value-based care, ultrasound/video-based artificial intelligence for medical procedures, as well as an app for patient empowerment in chronic pain. He has a unique interest in the use of technology to improve the perioperative experience and is working to build a new system of surgical risk prediction and management. He hopes to improve the quality and care of patients before and after discharge.

“The complexity and exponential growth of patient-generated data in modern care settings can be overwhelming, and even act as a barrier to real-time patient care and interventions if not properly managed,” said Dr. Setty. “I am excited to sharing my perspectives and experiences as a physician with Bernoulli to better facilitate the use of comprehensive real-time patient data to improve patient safety, quality and cost of care.”

“Many of the challenges facing healthcare providers – including mitigating patient safety threats, embarking on value-based care initiatives, and streamlining clinical workflows – require comprehensive real-time data, surveillance and analytics,” said Janet Dillione, CEO of Bernoulli. “Dr. Setty and Dr. Halpern’s clinical expertise will help uncover valuable insights, enabling us to better align our solutions with the needs of hospitals and health systems.”

For more information visit our Resource Center to download case studies, white papers and articles.

Bernoulli Demonstrates Real-Time Patient Data and Waveform Delivery with Voalte and Connexall at HIMSS17

Bernoulli will join Voalte and Connexall for a unique integration demonstration delivering alerts paired with real-time patient data and waveforms to smartphones. The demonstration will be held at Booth 673 at the 2017 Annual HIMSS Conference & Exhibition (HIMSS17) in Orlando next week. Click here for more details.